For research use only. Not for therapeutic Use.
Fluorodopa F18 (CAS 92812-82-3) is a radiopharmaceutical used in positron emission tomography (PET) imaging to visualize dopamine activity in the brain. This compound is a fluorine-18 labeled form of levodopa, a precursor of dopamine. By incorporating a positron-emitting isotope, Fluorodopa F18 allows for non-invasive imaging of dopamine-related processes, aiding in the diagnosis and monitoring of conditions such as Parkinson’s disease. The fluorine-18 radioisotope has a short half-life, making it suitable for PET imaging studies.
| Catalog Number | I048020 |
| CAS Number | 92812-82-3 |
| Synonyms | Fluorodopa F 18; F-DOPA; Fluorodopa (18F); L-6-(18F)Fluoro-DOPA; 6-(18F)Fluorodopamine; 6-(18F)Fluoro-L-DOPA; |
| Molecular Formula | C9H1018FNO4 |
| Purity | 98% |
| Target | Aromatic-L-amino-acid decarboxylase |
| Target Protein | PAXWQORCRCBOCU-RPDRGXCHSA-N |
| Appearance | Solid |
| IUPAC Name | (2S)-2-amino-3-(2-(18F)fluoranyl-4,5-dihydroxyphenyl)propanoic acid |
| InChI | InChI=1S/C9H10FNO4/c10-5-3-8(13)7(12)2-4(5)1-6(11)9(14)15/h2-3,6,12-13H,1,11H2,(H,14,15)/t6-/m0/s1/i10-1 |
| InChIKey | PAXWQORCRCBOCU-RPDRGXCHSA-N |
| SMILES | C1=C(C(=CC(=C1O)O)F)CC(C(=O)O)N |
